Waltham, Mass. — May 7, 2026 — Leads & Copy — Repligen Corporation (NASDAQ:RGEN) will participate in the Bank of America Securities 2026 Global Healthcare Conference, which will be held May 12-14 in Las Vegas, Nevada.
Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion on May 12 at 10:00 a.m. PT.
A live webcast of the conference presentation will be accessible through Repligen’s Investor Relations website at www.repligen.com. The webcast will be available for replay for a limited time following the event.
Repligen Corporation is a global life sciences company that develops and commercializes innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company says it is “inspiring advances in bioprocessing” for its customers, primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Repligen’s focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins.
The company’s corporate headquarters are located in Waltham, Massachusetts, and the majority of its manufacturing sites are in the U.S., with additional key sites in Estonia, Germany, Ireland, the Netherlands and Sweden.
Source: Repligen Corporation
